Propolis spray for the treatment of oral Mucositis

Propolis spray for oral Mucositis in head and neck chemotherapy patients – pilot study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-5cghb5n

Enrollment

Unknown

Registered

2025-09-18

Start date

2025-05-12

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis

Interventions

Propolis spray for the treatment of oral mucositis. This is a quantitative epidemiological study, called a randomized controlled clinical trial, aimed at evaluating the efficacy of propolis spray in t

D05.750.078.840.762

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with head and neck cancer; patients undergoing chemotherapy with or without associated radiotherapy; patients over 18 years of age of both sexes

Exclusion criteria

Exclusion criteria: Patients with metastasis;patients undergoing chemotherapy as palliative care; patients with allergies to propolis or any substance contained in the spray formula; patients unable to complete the questionnaires or in a serious condition that prevents them from participating in the study

Design outcomes

Primary

Measure	Time frame
Effective treatment of oral mucositis is expected	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Brazil

Contacts

Public ContactFernanda Dantas

Universidade Federal de Pernambuco

fernandasbdantas@gmail.com+55 (81) 2126.8000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)